Starting a new therapy for tuberous sclerosis complex (TSC) can lead to a lot of questions. We are glad you’re here to learn more about TORPENZ™. Below, we’ve provided responses to a few of the common questions we’ve heard from TSC caregivers and patients, to help you on your learning journey. Our goal is to provide you with the knowledge and support you need to navigate this journey with confidence.
The medication in TORPENZ™, everolimus, belongs to the class of medications called mTOR inhibitors. When everolimus is used for TSC, the medication works by shrinking TSC-associated brain (SEGA) and kidney tumors and may prevent new ones from growing. It does this in part by helping to control cell division and growth.
If you’re just starting on TORPENZ™, our Patient Information for TSC is a great place to start.
This covers the most important information you should know about TORPENZ™ Tablets.
When everolimus is used by people with TSC, it is NOT being used as a chemotherapy, since the tumors in TSC are not cancerous. But sometimes, everolimus IS referred to as chemotherapy, leading caregivers and patients to wonder why a cancer medication has been prescribed for TSC.
Everolimus works in part by helping to control cell division and growth. It has been studied in hundreds of trials in different conditions that are associated with abnormal cell division and growth. These include tumors that are benign (not cancer), such as those that occur in TSC, as well as some tumors that are cancerous. When everolimus is used by people with TSC, it is NOT being used as a chemotherapy, since the tumors in TSC are not cancerous.